Clostridium difficile infection: new developments in epidemiology and pathogenesis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Clostridium difficile is now considered to be one of the most important causes of health care-associated infections. C. difficile infections are also emerging in the community and in animals used for food, and are no longer viewed simply as unpleasant complications that follow antibiotic therapy. Since 2001, the prevalence and severity of C. difficile infection has increased significantly, which has led to increased research interest and the discovery of new virulence factors, and has expanded and focused the development of new treatment and prevention regimens. This Review summarizes the recent epidemiological changes in C. difficile infection, our current knowledge of C. difficile virulence factors and the clinical outcomes of C. difficile infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, studies have demonstrated that patients suffering from recurrent CDI are deficient in phyla of bacteria normally dominant in the colon6,45 (Figure 1).”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [45]
Citations
Cites
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 1×
“It is becoming evident from 16S ribosomal RNA sequencing that disruption of the gut microbiota following antibiotic treatment is much greater than was previously realize”
BackgroundAn Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Glucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Research works printed but not linked: 5
- Summary points on quarterly (October to December. 2008) and financial year (2007/08) acute Trust Clostridium difficile data. Key points: analyses of quarterly mandatory Clostridium difficile surveillance data. Health Protection Agency [online] , (2008).
- Thompson, A. et al. in Ninth Biennial Congress of the Anaerobe Society of Americas. PII-14 (Long Beach, California, 2008).
- Angulo, F. et al. in Second International Clostridium difficile Symposium. P5 (Maribor, Slovenia, 2007).
- Louie, T. et al. in The 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. K-425a (Chicago, Illinois, 2007).
- Merrigan, M. M., Gerding, D. N. & Vedantam, G. in Eighth Biennial Conference of the Anaerobe Society of America. PI-12 (Boise, Idaho, 2006).
Cited by
Items 901–999 of 999
Host Immunity to Clostridium difficile PCR Ribotype 017 Strains
Jafari, N. V., Songane, M., Stabler, R. A., Elawad, M., Wren, B. W., Allan, E., & Bajaj‐Elliott, M. (2014) · Infection and Immunity · doi:10.1128/iai.02605-14 · Cited by 11
“Although the increased rates of CDI have been primarily attributed to RT027, other emerging PCR ribotypes, such as RT001, RT017, and RT078, have been implicated in recent outbreaks which, in common with CDI due to RT027 strains, also show an increase in disease severity (1, 9, 10).”
BackgroundGenome Sequence and Analysis of Peptoclostridium difficile Strain ZJCDC-S82
Luo, Y., Huang, C., Ye, J., Fang, W. J., Gu, W., Chen, Z., Li, H., Wang, X., & Jin, D. (2016) · Evolutionary Bioinformatics · doi:10.4137/ebo.s32476 · Cited by 11
Clostridium difficile infections: an emerging problem in healthcare facilities
Cristina, M. L., Spagnolo, A. M., Sartini, M., Panatto, D., & Perdelli, F. (2012) · Reviews in Medical Microbiology · doi:10.1097/mrm.0b013e3283573643 · Cited by 11
“Possible community sources of CDI include soil, water, pets, meats and vegetables [22].”
BackgroundOkugawa, S., Yuhashi, K., Yagihara, Y., Miasawa, Y., Sato, T., Saito, R., & Moriya, K. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s105429 · Cited by 12
Clostridioides (Clostridium) Difficile Infection: Current and Alternative Therapeutic Strategies
Gil, F., Calderón, I. L., Fuentes, J. A., & Paredes‐Sabja, D. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0203 · Cited by 13
de Curraize, C., Rousseau, C., Corvec, S., El-Helali, N., Fihman, V., Barbut, F., Collignon, A., & Monnier, A. L. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3372-x · Cited by 11
Clostridioides difficile in bat guano
Bandelj, P., Knapič, T., Rousseau, J. D., Podgorelec, M., Presetnik, P., Vengušt, M., & Weese, J. S. (2019) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2019.05.016 · Cited by 11
Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation
Duclaux‐Loras, R., Berthiller, J., Ferroni, A., Chardot, C., Goulet, O., Lacaille, F., & Norsa, L. (2019) · Transplantation · doi:10.1097/tp.0000000000002795 · Cited by 11
“The colitis can cause a mild to severe diarrhea, sometimes complicated by protein-losing enteropathy or bacteraemia.(3) The incidence and severity of C.”
BackgroundFirst Microbiological and Molecular Identification ofRhodococcus equiin Feces of Nondiarrheic Cats
de Paula, C. L., Silva, R. O. S., Hernandes, R. T., de Nardi, G., Babboni, S. D., Guerra, S. T., Listoni, F. J. P., Giuffrida, R., Takaı̈, S., Sasaki, Y., et al. (2019) · BioMed Research International · doi:10.1155/2019/4278598 · Cited by 11
“difficile strains produce A and/or B toxins encoded by the genes tcdA and tcdB, respectively [44], as well as binary toxin (CDT), which is related to some ribotypes, including pet animals [45].”
BackgroundManganese superoxide dismutase from human pathogen Clostridium difficile
Li, W., Wang, H., Lei, C., Ying, T., & Tan, X. (2015) · Amino Acids · doi:10.1007/s00726-015-1927-z · Cited by 11
“It can produce toxins A and B, and causes an acute illness called Clostridium difficile infection (CDI) in humans, with symptoms ranging from severe diarrhea, antibiotic-associated colitis, pseudomembranous colitis, toxic megacolon, intestinal perforations, and ultimately to death (Rupnik et al. 2009).”
BackgroundOccurrence of Clostridium difficile in Raw Bovine, Ovine, Caprine, Camel and Buffalo Milk in Iran
Rahimi, E., Momtaz, H., & Hemmati, M. (2014) · Kafkas Universitesi Veteriner Fakultesi Dergisi · doi:10.9775/kvfd.2013.10175 · Cited by 11
“difficile also appears to be an important cause of enteric disease in a wide variety of animal species [7-10], suggesting that animals and humans may share a common source [11,12].”
BackgroundClostridium difficile carriage in healthy pregnant women in China
Ye, G., Li, N., Chen, Y., Lv, T., Shen, P., Gu, S., Fang, Y., & Li, L. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.11.010 · Cited by 11
MALDI-TOF MS: An alternative approach for ribotyping Clostridioides difficile isolates in Brazil
Carneiro, L. G., Pinto, T. C. A., Moura, H., Barr, J. R., Domingues, R. M. C. P., & Ferreira, E. D. O. (2021) · Anaerobe · doi:10.1016/j.anaerobe.2021.102351 · Cited by 10
Simpson, H. L., Roberts, C. L., Thompson, L. M., Leiper, C. R., Gittens, N., Trotter, E., Duckworth, C. A., Papoutsopoulou, S., Miyajima, F., Roberts, P., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.766293 · Cited by 13
“In recent years, the incidence of CDI has rapidly increased, and the disease is becoming associated with higher rates of morbidity and mortality (Rupnik et al., 2009; Freeman et al., 2010).”
BackgroundLi, Y., Xu, W., Ren, Y., Cheung, H., Huang, P., Kaur, G., Kuo, C., McDonough, S. P., Fubini, S. L., Lipkin, S. M., et al. (2022) · mBio · doi:10.1128/mbio.01849-22 · Cited by 10
Wen, G.-L., Li, S., Qin, Z., Yang, Y., Bai, L., Ge, W.-B., Liu, X., & Li, J. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1032945 · Cited by 10
Thran, M., Poenisch, M., Danz, H., Horscroft, N., Ichtchenko, K., Tzipori, S. R., & Shoemaker, C. B. (2023) · Scientific Reports · doi:10.1038/s41598-023-41092-7 · Cited by 11
Rui, W., Li, X., Li, Y., Meng, L., & Yang, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.103680 · Cited by 10
PCR Detection of Clostridium difficile and its Toxigenic Strains in Public Places in Southeast Ohio
Higazi, T. B., Al-Saghir, M., Burkett, M., & Pusok, R. (2011) · Cited by 10
Clostridium-difficile-assoziierte Infektionen im Kindes- und Jugendalter
Weichert, S., Simon, A., von Müller, L., Adam, R., & Schroten, H. (2015) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-014-3253-z · Cited by 11
Pessach, I., Tsirigotis, P. D., & Nagler, A. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1288566 · Cited by 12
Perspectivas históricas y vigentes sobre la infección por Clostridium difficile
Álvarez-Hernández, D.-A., González-Chávez, A., Hermosillo-Cornejo, D. G., Kelly, G. A. F., Díaz-Girón-Gidi, A., & Vázquez-López, R. (2017) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2017.03.004 · Cited by 14
No appendix necessary: Fecal transplants and antibiotics can resolve Clostridium difficile infection
Joshi, T., Elderd, B. D., & Abbott, K. C. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.01.013 · Cited by 10
Evaluation of functionality of type II toxin-antitoxin systems of Clostridioides difficile R20291
Alvarez, R. J., Ortega, C., Queraltó, C., Inostroza, O., Díaz-Yáñez, F., Gonzalez, R. M., Calderón, I. L., Fuentes, J. A., Paredes‐Sabja, D., & Gil, F. (2020) · Microbiological Research · doi:10.1016/j.micres.2020.126539 · Cited by 10
Zhao, W., Huang, Y., Cui, N., Wang, R., Xiao, Z., & Su, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1100465 · Cited by 14
“, 2015), similar to Clostridium difficile (Rupnik et al., 2009; Buffie et al., 2012).”
Hernández-Rocha, C., Pidal, P., Ajenjo, M. C., Quera, R., Quintanilla, M., Lubascher, J., Jemenao, M. I., Patricio Ibáñez, L., Álvarez-Lobos, M., Alexis Diomedi, P., et al. (2016) · Revista chilena de infectología · doi:10.4067/s0716-10182016000100020 · Cited by 13
Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel
Na’amnih, W., Adler, A., Miller-Roll, T., Cohen, D., & Carmeli, Y. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3247-1 · Cited by 10
Förster, B., Chung, P. K., Crobach, M. J. T., & Kuijper, E. J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01382 · Cited by 10
“However, it is also the most important cause of infectious antibiotic- and healthcare-associated diarrhea (Rupnik et al., 2009; Magill et al., 2014).”
BackgroundThe Selenophosphate Synthetase Gene, selD , Is Important for Clostridioides difficile Physiology
McAllister, K. N., Aguirre, A. M., & Sorg, J. A. (2021) · Journal of Bacteriology · doi:10.1128/jb.00008-21 · Cited by 10
“This pathogen has become the most common cause of health care-associated infections in United States hospitals (2, 3).”
BackgroundIlchmann, C., Zaiss, N. H., Speicher, A., Christner, M., Ackermann, G., & Rohde, H. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1017-9 · Cited by 10
“difficile PCR ribotype 027 contributed to the ever increasing number of CDI cases in regions with epidemic outbreaks [1]; however, spread of this strain is clearly not the exclusive reason for the changing epidemiology and clinical presentation of CDI in general.”
BackgroundInfluentialDeshpande, A., Dureja, C., McKelvey, A. M., Zhao, W., Rutherford, J. T., Olaitan, A. O., & Hurdle, J. G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.03.482942 · Cited by 11
Marini, E., Olivença, C., Ramalhete, S., Aguirre, A. M., Ingle, P., Melo, M. N., Antunes, W., Minton, N. P., Hernández, G., Cordeiro, T. N., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011741 · Cited by 8
López-Timoner, R., Santos‐Juanes, L., Amat, A. M., Arfelli, F., Cespi, D., Passarini, F., Polo, M. I., Zuriaga-Agustí, E., & Arques, A. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.179029 · Cited by 10
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
Maaß, S., Bartel, J., Mücke, P.-A., Schlüter, R., Sura, T., Zaschke-Kriesche, J., Smits, S. H. J., & Becher, D. (2021) · Cells · doi:10.3390/cells10020372 · Cited by 9
“difficile infection (CDI) is the leading cause of antibioticsassociated diarrhea [19] but can also result in more serious, life-threatening conditions such as pseudomembranous colitis, toxic megacolon, and intestinal perforation [20,21].”
BackgroundClostridioides difficile: Current overview and future perspectives
Giles, J. L., & Roberts, A. K. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.11.003 · Cited by 15
Kim, J. N., Kim, J. H., Lee, H. J., Lee, S. J., Kim, C., Lee, J. A., Lee, S. H., Pyo, W. K., Ahn, J. Y., Jeong, S. J., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12010173 · Cited by 10
“Antibiotics also increase the risk of CDI by disrupting the gut microbiome [13].”
BackgroundInfluentialBustin, K. A., Abbas, A. A., Wang, X., Abt, M. C., Zackular, J. P., & Matthews, M. L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1074619 · Cited by 12
“difficile infection (CDI) and pathogenesis are driven by two toxins, toxin A (tcdA) and toxin B (tcdB), which cause a wide range of symptoms including diarrhea, pseudomembranous colitis, toxic megacolon and/ or death (Rupnik et al., 2009; Carter et al., 2010).”
BackgroundAuria, E., Hunault, L., England, P., Monot, M., da Fonseca, J. P., Matondo, M., Duchateau, M., Tremblay, Y. D. N., & Dupuy, B. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00393-5 · Cited by 10
Advances in Therapeutic Strategies for the Management of Clostridioides difficile Infection
Vitiello, A., Sabbatucci, M., Zovi, A., Salzano, A., Ponzo, A., & Boccellino, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051331 · Cited by 12
Senoh, M., Iwaki, M., Yamamoto, A., Kato, H., Fukuda, T., & Shibayama, K. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.03.001 · Cited by 9
Mackin, K. E., Elliott, B., Kotsanas, D., Howden, B. P., Carter, G. P., Korman, T. M., Riley, T. V., Rood, J. I., Jenkin, G., & Lyras, D. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.05.001 · Cited by 9
“has been linked to fluoroquinolone-resistant toxinotype III/ ribotype 027 strains, which may be more virulent than other strain types [6,7].”
BackgroundNovel Management Strategies in the Treatment of Severe Clostridium difficile Infection
Nassour, I., Carchman, E. H., Simmons, R. L., & Zuckerbraun, B. S. (2012) · Advances in Surgery · doi:10.1016/j.yasu.2012.03.009 · Cited by 9
Novel inhibitors of surface layer processing in Clostridium difficile
Dang, T. H. T., Fagan, R. P., Fairweather, N. F., & Tate, E. W. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.042 · Cited by 17
Novel therapeutic strategies for Clostridium difficile infections
Ünal, C., & Steinert, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1090428 · Cited by 13
“While generally spoken all antibiotic treatments have this side effect, clindamycin, cephalosporin and fluoroquinolones carry a higher risk for the development of the disease [4].”
BackgroundInfluentialSchoster, A., & Staempfli, H. R. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0029-3 · Cited by 9
Prevalence of Clostridium difficile and its toxigenic genotype in beef samples in west of Iran.
Kheradmand, M., Jalilian, S., Alvandi, A., & Abiri, R. (2017) · PubMed Central · Cited by 9
Winter, K., Xing, L., Kassardjian, A., & Ward, B. J. (2019) · Infection and Immunity · doi:10.1128/iai.00089-19 · Cited by 12
“Clostridium difficile is one of the most important nosocomial pathogens in the world (1, 2).”
Kang, C.-Y., Huang, I., Chou, C., Wu, T.-Y., Chang, J.-C., Hsiao, Y.-Y., Cheng, C.-H., Tsai, W., Hsu, K., & Wang, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011322 · Cited by 9
“difficile is a Gram-positive, spore-forming, and anaerobic bacterium (6), which is the causing agent of a multitude of intestinal diseases ranging from mild diarrhea to severe inflammatory bowel perforations or pseudomembranous colitis (7, 8).”
BackgroundGranata, G., Mariotti, D., Ascenzi, P., Petrosillo, N., & di Masi, A. (2021) · Antibiotics · doi:10.3390/antibiotics10091093 · Cited by 11
“TcdA and TcdB monoglucosylate and inactivate the Rho GTPases of host cells, causing several cytopathic effects, and ultimately colonocyte death and loss of intestinal barrier function [8,9].”
BackgroundKarpiński, P., Wultańska, D., Piotrowski, M., Brajerova, M., Mikucka, A., Pituch, H. M., & Krůtová, M. (2021) · Anaerobe · doi:10.1016/j.anaerobe.2021.102476 · Cited by 9
Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection
Lang, V., Gunka, K., Ortlepp, J. R., Zimmermann, O., & Groß, U. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.840846 · Cited by 10
Clostridium difficile infection in the elderly.
Bella, S. D., Capone, A., Musso, M., Giannella, M., Tarasi, A., Johnson, E., Taglietti, F., Campoli, C., & Petrosillo, N. (2013) · PubMed · Cited by 9
Esporas de Clostridium difficile y su relevancia en la persistencia y transmisión de la infección
Barra-Carrasco, J., Hernández-Rocha, C., Patricio Ibáñez, L., Guzmán-Durán, A. M., Álvarez-Lobos, M., & Paredes‐Sabja, D. (2014) · Revista chilena de infectología · doi:10.4067/s0716-10182014000600010 · Cited by 19
Hospital roommates and development of health care–onset Clostridium difficile infection
Echaiz, J. F., Veras, L. V., Zervos, M. J., Dubberke, E. R., & Johnson, L. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.06.023 · Cited by 9
Huang, B., Li, H., Jin, D., Stratton, C. W., & Tang, Y. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.900442 · Cited by 9
“As previously described [3,8], culture and/or GDH EIA only detect the presence of C.”
BackgroundActualités épidémiologiques et thérapeutiques des infections à Clostridium difficile
Dinh, A., Bouchand, F., & Monnier, A. L. (2015) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2015.02.003 · Cited by 15
Senoh, M., Iwaki, M., Yamamoto, A., Kato, H., Fukuda, T., & Shibayama, K. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.06.039 · Cited by 9
Ünal, C., Karagöz, M. S., Berges, M., Priebe, C., Acuña, J. M. B., Wissing, J. B., Jänsch, L., Jahn, D., & Steinert, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00340 · Cited by 10
Sung, S., Kwon, J.-W., Lee, S., Lee, H., Moon, S.-H., & Lee, B. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-61327-1 · Cited by 9
Structure and assembly of a Clostridioides difficile spore polar appendagePreprint
Antunes, W., Pereira, F. C., Feliciano, C. A., Saujet, L., Vultos, T. D., Couture‐Tosi, E., Péchiné, S., Bruxelle, J.-F., Janoir, C., Melo, L. V., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/468637 · Cited by 10
“…changes in the epidemiology of this pathogen, together with its emergence at the community level and the risk of widespread zoonotic transmission, adds to the problem (Dubberke & Olsen, 2012, Isidro et al., 2018, Jones et al., 2013, Lessa et al., 2015, Rupnik et al., 2009, Smits et al., 2016).”
BackgroundInfluentialDisparate subcellular location of putative sortase substrates in Clostridium difficile
Peltier, J., Shaw, H. A., Wren, B. W., & Fairweather, N. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-08322-1 · Cited by 8
Jia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
Chiang, S., Lai, C., Ho, C., Chen, C., Chao, C., Wang, J., & Cheng, K.-C. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7080224 · Cited by 8
“CDI is believed to be precipitated by antimicrobial therapy, the most significant risk factor [7,8], which causes a disruption of the normal colonic microbiota; this disruption predisposes patients to C.”
BackgroundDonnelly, M. L., Forster, E. R., Rohlfing, A. E., & Shen, A. (2020) · Biochemical Journal · doi:10.1042/bcj20190875 · Cited by 10
Whitney, L., Nesnas, J., & Planche, T. (2023) · Antibiotics · doi:10.3390/antibiotics12010106 · Cited by 12
“difficile infection (CDI) is the most common cause of infectious nosocomial diarrhoea, with other symptoms including severe abdominal pain, fever and leucocytosis [3].”
BackgroundBarezi, A. A., Shakerian, A., Rahimi, E., & Esfandiari, Z. (2023) · BioMed Research International · doi:10.1155/2023/3524091 · Cited by 8
“Fluoroquinolone antibiotics (such as ciprofloxacin) and tetracycline are widely used in the livestock diet and are even used to treat diseases that can cause antibiotic residues in animal meat [10].”
BackgroundClostridium difficile infection in pediatric patients (Review)
Dop, D., Marcu, I. R., Pădureanu, V., Caragea, D. C., Pădureanu, R., Niculescu, Ș. A., & Niculescu, C. (2023) · Biomedical Reports · doi:10.3892/br.2023.1706 · Cited by 8
“…may be considered a constituent of the normal microbiota, but under specific conditions that disrupt the normal intestinal microbiota, it colonizes the large intestine causing, through the action of its toxins, varying degrees of colonic damage, ranging from mild diarrhea to toxic mega‑ colon (5).”
BackgroundZhu, X., Gu, X., Zhang, S., Liu, Y., Huang, Z., & Tan, X. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.02.006 · Cited by 8
“difficile infection (CDI)(1) in humansranging from severe diarrhea, antibiotic-associated colitis, pseudomembranous colitis, toxic megacolon, intestinal perforations and even Death [1].”
BackgroundJabbari, S., Cartman, S. T., & King, J. R. (2014) · Journal of Mathematical Biology · doi:10.1007/s00285-014-0780-0 · Cited by 10
“…Jabbari (B) School of Mathematics and Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK e-mail: s.jabbari@bham.ac.uk S. T. Cartman Clostridia Research Group, Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK J. R. King…”
BackgroundMicrobiota: A Key for Healthy Aging
Choi, Y. J., & Lee, D. H. (2016) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.2016.20.4.168 · Cited by 8
Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients
Messick, C. A., Hammel, J. P., & Hull, T. L. (2017) · The American Surgeon · doi:10.1177/000313481708300633 · Cited by 8
Androga, G. O., Knight, D. R., Hutton, M. L., Mileto, S. J., James, M. L., Evans, C. J., Lyras, D., Chang, B. J., Foster, N. F., & Riley, T. V. (2019) · Anaerobe · doi:10.1016/j.anaerobe.2019.102083 · Cited by 7
Lachowicz, D., Pituch, H. M., Wultańska, D., Kuijper, E. J., & Obuch-Woszczatyński, P. (2020) · Anaerobe · doi:10.1016/j.anaerobe.2020.102167 · Cited by 8
Aminzadeh, A., Tiwari, M. K., Mustapha, S. S. M., Navarrete, S. J., Henriksen, A. B., Møller, I. M., Krogfelt, K. A., Bjerrum, M. J., & Jørgensen, R. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.021 · Cited by 9
Luo, P., & Liu, Y. (2020) · Letters in Applied Microbiology · doi:10.1111/lam.13383 · Cited by 8
“Clostridium difficile is one of the most predominant pathogens of nosocomial intestinal infections, which can cause antibiotic-associated diarrhoea or pseudo-membranous colitis in humans and animals (Rupnik et al. 2009; Barbut et al. 2011; Martin et al. 2014; Balsells et al. 2016).”
BackgroundRaw Animal Meats as Potential Sources of Clostridium difficile in Al-Jouf, Saudi Arabia
Taha, A. E. (2021) · Food Science of Animal Resources · doi:10.5851/kosfa.2021.e44 · Cited by 10
Zaver, H. B., Moktan, V. P., Harper, E. P., Bali, A. S., Nasir, A., Foulks, C., Kuhlman, J. J., Green, M. E., Algan, G. A., Parth, H. C., et al. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.09.004 · Cited by 8
“Health care facilityeonset CDI was defined as a positive stool specimen collected more than 3 calendar days after hospital admission per CDC surveillance definition.(2,3)”
BackgroundMethodHorvat, S., Mahnič, A., Makuc, D., Pečnik, K., Plavec, J., & Rupnik, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1042526 · Cited by 8
“org toxigenic profile, ribotype) and host factors (i.e., age, immune response; Rupnik et al., 2009; Leffler and Lamont, 2015).”
BackgroundVázquez‐Cuesta, S., Lozano-García, N., Fernández, A. I., Olmedo, M., Kestler, M., Alcalá, L., Marín, M., Bermejo, J., Díaz, F. F.-A., Muñóz, P., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1237500 · Cited by 9
“The clinical severity of Clostridioides difficile infection ranges from asymptomatic, mild, moderate and severe episodes and pseudomembranous colitis to toxic megacolon, sepsis or death (Rupnik et al., 2009).”
BackgroundProgress with a difficult infection
Wilcox, M. H. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70013-0 · Cited by 8
Li, W., Wang, H., Chen, Z., Ye, Q., Tian, Y., Xu, X., Huang, Z., Li, P., & Tan, X. (2013) · Chemical Communications · doi:10.1039/c3cc47859a · Cited by 8
ANTIBIOTIC-ASSOCIATED DIARRHEA AND CL. DIFFICILE-INFECTION IN CHILDREN: RISK FACTORS
Mazankova, L. N., & Perlovskaya, S. G. (2015) · CHILDREN INFECTIONS · doi:10.22627/2072-8107-2015-14-2-29-34 · Cited by 9
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?
Posteraro, B., Pea, F., Masucci, L., Posteraro, P., & Sanguinetti, M. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1452908 · Cited by 10
“anaerobic bacterium that is able to thrive and to colonize the large intestine, causing symptoms that range from mild diarrhea to severe colitis – inflammation of the large intestine – which can lead to toxic megacolon and/or death [14].”
BackgroundÜnal, C., Berges, M., Smit, N., Schiene‐Fischer, C., Priebe, C., Strowig, T., Jahn, D., & Steinert, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02913 · Cited by 10
Ganji, A., Islami, M., Ejtehadifar, M., Zarei-Mehrvarz, E., & Darvish, M. (2019) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000175 · Cited by 8
“exotoxins: toxin A (TcdA) and toxin B (TcdB), responsible for epithelial barrier disruption and colon pseudomembrane formation, diarrhea, inflammation and recurrent relapse in treated patients [35,36].”
BackgroundNaz, F., Hagspiel, N., Xu, F., Thompson, B. A., Moreau, G. B., Young, M., Herbein, J. F., Fox, C. B., Petri, W. A., & Abhyankar, M. M. (2025) · npj Vaccines · doi:10.1038/s41541-025-01075-3 · Cited by 9
Wynell Mayow, W., Cash, D. J. W., Muniz Tererra, G., Gkrania‐Klotsas, E., & Khanduja, V. (2017) · Archives of Clinical Microbiology · doi:10.4172/1989-8436.100046 · Cited by 9
Therapie akuter und rekurrenter Clostridium-difficile-Infektionen
von Braun, A., & Lübbert, C. (2018) · Der Internist · doi:10.1007/s00108-018-0401-x · Cited by 7
Chamchod, F., & Palittapongarnpim, P. (2019) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-019-0098-0 · Cited by 7
Bacteria co-colonizing with Clostridioides difficile in two asymptomatic patients
Hong, W., Yang, J., Cheng, Y., Huang, X., Rao, F., Zhang, T., Wang, P., Liao, J., Qi, X., Guan, Z., et al. (2019) · Open Life Sciences · doi:10.1515/biol-2019-0071 · Cited by 7
Rosales‐Mendoza, S., Rincón, T. C., Romero‐Maldonado, A., Monreal‐Escalante, E., & Nieto‐Gómez, R. (2021) · Biotechnology Progress · doi:10.1002/btpr.3141 · Cited by 7
“stools, and minor abdominal cramping as well as more severe symptoms such as bloody diarrhea, pseudomembrane colitis, and toxic megacolon.(5)”
BackgroundJeng, H., & Yan, T. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-02837-6 · Cited by 9
Global research on Clostridium difficile-associated diarrhoea: A visualized study
Zyoud, S. H. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i28.3720 · Cited by 8
Golchha, N. C., Nighojkar, A., & Nighojkar, S. (2022) · Drug Target Insights · doi:10.33393/dti.2022.2469 · Cited by 11
“But later on, it was identified as the cause of antibiotic-associated PMC (10).”
BackgroundCAGS Clinical Practice Committee report: the science of Clostridium difficile and surgery
Karmali, S., Laffin, M., & de Gara, C. (2013) · Canadian Journal of Surgery · doi:10.1503/cjs.018413 · Cited by 7
“This disruption allows both toxins to then cross the epithelium, where toxin B binds preferentially to the basolateral cell membrane.(11) Both toxins are cytotoxic and induce the release of various immunomodulatory mediators.”
BackgroundThe Pharmacological Effects of Fagonia cretica linn Ethanolic Extract on Isolated Rabbit Intestine
Ahmed, A. A. E., Elfeil, M. E. H., Ahmed, S. K. N., & Elsammani, T. O. (2013) · International Journal of Pharmacology and Toxicology · doi:10.14419/ijpt.v1i2.1404 · Cited by 7
Stojanov, M., Magalhães, B., Terletsky, V. P., Basset, P., Prod’hom, G., Greub, G., Senn, L., & Blanc, D. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2525-4 · Cited by 7
Detection of toxigenic Clostridium difficile strains isolated from meat and meat products in Iran
Rahimi, E., & Khaksar, F. (2015) · BULGARIAN JOURNAL OF VETERINARY MEDICINE · doi:10.15547/bjvm.845 · Cited by 7
“In recent studies C. difficile has been isolated from several food animal species and variety of foodstuff, sharing high level of genetic similarity with those of human isolates (Simango, 2008; Rupnik et al., 2009; Weese, 2010).”
BackgroundHigh-mobility group box 1 protein contributes to the immunogenicity of rTcdB-treated CT26 cells
Gu, H., Ji, L., Chen, S., Qi, H., Shi, K., Li, S., Ma, Y., & Wang, J. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy078 · Cited by 6
Metadata
- Authors
- Rupnik, M., Wilcox, M. H., & Gerding, D. N.
- Affiliations
- University of Maribor (SI)
- Leeds General Infirmary (GB)
- Loyola University Chicago (US)
- Venue
- Nature Reviews Microbiology
- Published
- 2009-07
- Volume
- 7
- Issue
- 7
- Pages
- 526-536
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1968953113
- Cited by
- 1,380
- References
- 124
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 49 · 2023: 59 · 2022: 74 · 2021: 72 · 2020: 88 · 2019: 78 · 2018: 109 · 2017: 104 · 2016: 107 · 2015: 107 · 2014: 133 · 2013: 141 · 2012: 93
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Clostridium difficile infection, nosocomial infections, virulence factors, epidemiology, pathogenesis, community-acquired infections, food-producing animals, antibiotic-associated diarrhea, clinical outcomes, infection prevention and treatment
- MeSH terms
- Animals, Anti-Bacterial Agents, Enterocolitis, Pseudomembranous, Humans, Models, Theoretical, Clostridioides difficile, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.